Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

786232

registered interest
date	07/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Endoscopy: Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many more NHS endoscopies will be performed annually by 2020 by the clinical endoscopists being trained through the accelerated training programme.
tabling member constituency	Cumbernauld, Kilsyth and Kirkintilloch East
tabling member printed	Stuart C. McDonald
uin	111915
answer	answer is ministerial correction date of answer 13/11/2017 answer text <p>Health Education England estimate that the additional 200 clinical endoscopists being trained through the accelerated training programme will result in approximately 225,000 additional procedures a year.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 13/11/2017 15:27:22 answering member 1542 label Biography information for Philip Dunne
tabling member	4393 label Biography information for Stuart C McDonald

786233

registered interest
date	07/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Endoscopy: Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many clinical endoscopists have been trained as part of the accelerated training programme.
tabling member constituency	Cumbernauld, Kilsyth and Kirkintilloch East
tabling member printed	Stuart C. McDonald
uin	111916
answer	answer is ministerial correction date of answer 13/11/2017 answer text <p>To date, 48 clinical endoscopists have completed Health Education England’s (HEE) accelerated training programme, of which 17 completed training in 2017. A further 40 clinical endoscopists are currently in training across two cohorts and are due to complete the programme in December 2017 and April 2018.</p><p> </p><p>HEE plan a further three cohort intakes in 2018.</p><p> </p><p>Training of endoscopists outside of England is a matter for each of the devolved administrations in that country.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne grouped question UIN 111917 111942 question first answered 13/11/2017 15:31:22 answering member 1542 label Biography information for Philip Dunne
tabling member	4393 label Biography information for Stuart C McDonald

786235

registered interest
date	07/11/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Endoscopy: Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many clinical endoscopy cohorts have completed training in 2017 as part of the accelerated training programme.
tabling member constituency	Cumbernauld, Kilsyth and Kirkintilloch East
tabling member printed	Stuart C. McDonald
uin	111917
answer	answer is ministerial correction date of answer 13/11/2017 answer text <p>To date, 48 clinical endoscopists have completed Health Education England’s (HEE) accelerated training programme, of which 17 completed training in 2017. A further 40 clinical endoscopists are currently in training across two cohorts and are due to complete the programme in December 2017 and April 2018.</p><p> </p><p>HEE plan a further three cohort intakes in 2018.</p><p> </p><p>Training of endoscopists outside of England is a matter for each of the devolved administrations in that country.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne grouped question UIN 111916 111942 question first answered 13/11/2017 15:31:22 answering member 1542 label Biography information for Philip Dunne
tabling member	4393 label Biography information for Stuart C McDonald

720505

registered interest
date	13/04/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many reports of (a) all adverse and (b) serious adverse reactions to (i) Cervarix, (ii) Gardasil and (iii) generic human papilloma virus vaccines the Medicines and Healthcare Products Regulatory Agency has received to date.
tabling member constituency	Cumbernauld, Kilsyth and Kirkintilloch East
tabling member printed	Stuart C. McDonald
uin	70973
answer	answer is ministerial correction date of answer 24/04/2017 answer text <p>As with all vaccines and medicines, the Medicines and Healthcare products Regulatory Agency (MHRA) closely monitors the safety of human papillomavirus (HPV) vaccine. The MHRA takes advice from the Government's independent expert advisory body, the Commission on Human Medicines (CHM), when evaluating the risks and benefits of medicines and vaccines.</p><p> </p><p>A total of 8,835 suspected adverse reaction reports (ADRs) with HPV vaccines have been reported to the MHRA via the Yellow Card Scheme up to 17 April 2017. This follows administration of at least eight million doses of the vaccine since the immunisation programme began in 2008.</p><p> </p><p>It is important to note that a Yellow Card report is not proof of a side effect occurring, but a suspicion by the reporter that the vaccine may have been the cause. Whilst Yellow Card reports may represent side effects, they may also relate to coincidental events unrelated to vaccination. The CHM has thoroughly reviewed the data reported in association with HPV vaccines in the United Kingdom and has no concerns about the number or nature of Yellow Card reports received. The CHM considered that the vast majority of suspected side effects reports appeared to be similar in frequency and type to those that had been reported with other vaccines routinely given to adolescents and adults and concluded that the evidence does not support a link between HPV vaccination and chronic illnesses.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p>The possible known side effects, and the frequency, are listed in the product information which is provided with the vaccines. The vast majority of the 8,835 ADRs relate to the known risks of vaccination that are well-described in the available product information. The expected benefits in protecting against HPV-related mortality and disease outweigh the known side effects of HPV vaccine.</p><p> </p><p> </p><table><tbody><tr><td><p>Vaccine Brand</p></td><td><p>Total number of reports</p></td><td><p>Number of serious reports (% of total)</p></td></tr><tr><td><p>Cervarix</p></td><td><p>6,312</p></td><td><p>1,812 (29%)</p></td></tr><tr><td><p>Gardasil</p></td><td><p>1,858</p></td><td><p>767 (41%)</p></td></tr><tr><td><p>Gardasil 9</p></td><td><p>10</p></td><td><p>6 (60%)</p></td></tr><tr><td><p>HPV Brand unspecified</p></td><td><p>658</p></td><td><p>456 (69%)</p></td></tr><tr><td><p>Total for Human Papilloma virus vaccines</p></td><td><p>8,835*</p></td><td><p>3,038 (34%)</p></td></tr></tbody></table><p> </p><p>Source: MHRA sentinel database for adverse reactions.</p><p>Note that the total number of reports received will not be equal to the totals in the table above as some reports of suspected adverse reactions may have included more than one vaccine.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 24/04/2017 17:18:32 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4393 label Biography information for Stuart C McDonald

720508

registered interest
date	13/04/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Research
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that new drugs developed in part with financial support from government are made available to NHS patients.
tabling member constituency	Cumbernauld, Kilsyth and Kirkintilloch East
tabling member printed	Stuart C. McDonald
uin	70879
answer	answer is ministerial correction date of answer 24/04/2017 answer text <p>Through its technology appraisal programme, the National Institute for Health and Care Excellence (NICE) provides authoritative, evidence-based guidance for the National Health Service on the clinical and cost effectiveness of new drugs and other treatments. NHS commissioners are legally required to fund drugs and treatments recommended in NICE technology appraisal guidance.</p><p> </p><p>The Government wants patients to access cost effective, innovative drugs and technologies quickly at a price that the NHS can afford and to create a more attractive environment for innovators. That is why we commissioned the Accelerated Access Review, which reported in October 2016.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 24/04/2017 16:47:49 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4393 label Biography information for Stuart C McDonald

720509

registered interest
date	13/04/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that existing and cost-effective drugs which have been shown to be effective in reducing the risk of recurrence and spread of incurable cancer are repurposed as quickly as possible.
tabling member constituency	Cumbernauld, Kilsyth and Kirkintilloch East
tabling member printed	Stuart C. McDonald
uin	70880
answer	answer is ministerial correction date of answer 24/04/2017 answer text <p>The Government is working with a range of organisations, including the Association of Medical Research Charities, to ensure that robust evidence showing new uses for existing drugs can be brought more systematically into clinical practice to benefit patients.</p><p> </p><p>Significant progress has been made in designing a ‘drug re-purposing pathway’ to help the charities and others to navigate a route through the National Health Service so that they can see how research can be shared at a national level and then picked up locally where it can reach the patient. Work on this is continuing.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 24/04/2017 17:06:50 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4393 label Biography information for Stuart C McDonald

709966

registered interest
date	10/03/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans he has to reduce the screening age for bowel cancer to 50-years old.
tabling member constituency	Cumbernauld, Kilsyth and Kirkintilloch East
tabling member printed	Stuart C. McDonald
uin	67382
answer	answer is ministerial correction date of answer 16/03/2017 answer text <p>I refer the hon. Member to the answer I gave to the hon. Member for Dulwich and West Norwood (Helen Hayes MP) on 10 March 2017 to Question <a href="http://www.parliament.uk/business/publications/written-questions-answers-statements/written-questions-answers/?page=1&amp;max=20&amp;questiontype=AllQuestions&amp;house=commons%2clords&amp;uin=66349" target="_blank">66349</a>.</p> answering member constituency Warrington South answering member printed David Mowat question first answered 16/03/2017 10:26:28 answering member 4080 label Biography information for David Mowat
tabling member	4393 label Biography information for Stuart C McDonald

636224

registered interest
date	14/11/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Public Health England: Staff
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to item 7 of the substantive hearing of the Conduct and Competence Committee at the Nursing and Midwifery Council of 13 and 14 September 2016 on Pauline Cafferkey that found that the evidence indicates that PHE Screening staff were not properly prepared to receive so many travellers from at risk countries, whether he has made an assessment of the implications for his policies of that finding; and what steps he plans to take to ensure health screening of such travellers is adequately planned for and resourced in future.
tabling member constituency	Cumbernauld, Kilsyth and Kirkintilloch East
tabling member printed	Stuart C. McDonald
uin	528601
answer	answer is ministerial correction date of answer 21/11/2016 answer text <p>Working in partnership with the Border Force, Public Health England screened 14,500 passengers returning to the United Kingdom from West Africa during the Ebola outbreak. This was the first time that port of entry screening for an infectious disease had been implemented on this scale. The design and implementation of the screening process evolved throughout the course of the outbreak with ever more accurate information being gathered from partners overseas and shared in advance with the screening teams at the five major UK ports of entry.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood question first answered 21/11/2016 13:59:22 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4393 label Biography information for Stuart C McDonald